Expert guides, hospital insights, and medical travel tips for your China health journey
On January 2, 2025, China's NMPA approved its first-ever mesenchymal stem cell therapy. Here's what the science actually says — and what it means for patients.
A meta-analysis of 62 studies involving 2,439 spinal cord injury patients examined stem cell therapy outcomes. The data is more nuanced than the headlines — here's what it actually shows.
A study covering 6.4 million cancer patients across all 32 Chinese provinces published updated 5-year survival data. We break down what it says — and where China excels versus the West.
Panda Touring Care Newsletter
Research-backed guides on stem cell therapy, hospital quality data, and medical travel — delivered weekly.
No spam, ever. Unsubscribe anytime.